AccScience Publishing / ITPS / Volume 6 / Issue 2 / DOI: 10.36922/itps.0435
Cite this article
Journal Browser
Volume | Year
News and Announcements
View All

Tryptophan metabolism in schizophrenia

Dilceu Silveira Tolentino Júnior1* Heberson Teixeira da Silva2 Alessandro Martins Ribeiro1 Tales Alexandre Ferreira-Aversi2 Lízia Colares Vilela1
Show Less
1 Federal University of the Jequitinhonha and Mucuri Valley, Teófilo Otoni, Minas Gerais, Brazil
2 Department of Physics, Federal University of Alfenas, Alfenas, Minas Gerais, Brazil
INNOSC Theranostics and Pharmacological Sciences 2023, 6(2), 0435
Submitted: 13 April 2023 | Accepted: 19 July 2023 | Published: 4 August 2023
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( )
  1. Carvalho MS, Mas CD, Nunes DF, et al., 2017, Tryptophan metabolism in mental disorders: A focus on schizophrenia. Vittalle, 29: 44–56.


  1. McCusker RH, Kavelaars A, Heijnen CJ, et al., 2014, Depression, inflammation and tryptophan metabolism. In: The Wiley-blackwell Handbook of Psychoneuroimmunology. Hoboken, New Jersey: Wiley, p448–468.


  1. Menegatti R, Fraga CA, Barreiro EJ, et al., 2004, Schizophrenia: Forty years of the dopaminergic hypothesis from the perspective of medicinal chemistry. Quim Nova, 27: 447–455. s0100-40422004000300015


  1. Madras BK, Cohen EL, Messing R, et al., 1974, Relevance of free tryptophan in serum to tissue tryptophan concentrations. Metabolism, 23: 1107–1116.


  1. Curzon G, Friedel J, Knott PJ, 1974, The effect of fatty acids on the binding of tryptophan to plasma protein. Nature, 242: 198–200.


  1. Leblhuber F, Geisler S, Steiner K, et al., 2015, Elevated fecal calprotectin in patients with Alzheimer’s dementia indicates leaky gut. J Neural Transm (Vienna), 122: 1319–1322.


  1. Ruddick JP, Evans AK, Nutt DJ, et al., 2006, Tryptophan metabolism in the central nervous system: Medical implications. Exp Rev Mol Med, 8: 1–27.


  1. Reininghaus EZ, McIntyre RS, Reininghaus B, et al., 2014, Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: A preliminary report. Bipolar Disord, 16: 432–440.


  1. Anderson G, Jacob A, Bellivier F, et al., 2016, Bipolar disorder: The role of the kynurenine and melatonergic pathways. Curr Pharm Des, 22: 987–1012.


  1. Nguyen QT, Schroeder LF, Mank M, et al., 2010, An in vivo biosensor for neurotransmitter release and in situ receptor activity. Nat Neurosci, 13: 127–134.


  1. Díaz-Marsa M, Lozano C, Herranz AS, et al., 2006, Acute tryptophan depletion in eating disorders. Actas Esp Psiquiatr, 34: 397–402.


  1. Yang Y, Sauve AA, 2016, NAD(+) metabolism: Bioenergetics, signaling and manipulation for therapy. Biochim Biophys Acta, 1864: 1787–1800.


  1. Erhardt S, Schwieler L, Imbeault S, et al., 2017, The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology, 112: 297–306.


  1. Schwarcz R, Pellicciari R, 2002, Manipulation of brain kynurenines: Glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther, 303: 1–10.


  1. Hilmas C, Pereira EF, Alkondon M, et al., 2001, The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: Physiopathological implications. J Neurosci, 21: 7463–7473.


  1. Stone TW, 2020, Does kynurenic acid act on nicotinic receptors? An assessment of the evidence. J Neurochem, 152: 627–649.


  1. Lim CK, Bilgin A, Lovejoy DB, et al., 2017, Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci Rep, 7: 41473.


  1. Agudelo LZ, Femenia T, Orhan F, et al., 2014, Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell, 159: 33–45.


  1. Myint AM, Kim YK, 2014, Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis. Prog Neuropsychopharmacol Biol Psychiatry, 48: 304–313.


  1. Schwarcz R, Bruno JP, Muchowski PJ, et al., 2012, Kynurenines in the mammalian brain: When physiology meets pathology. Nat Rev Neurosci, 13: 465–477.


  1. Andresasen NC, Black DW, 2009, Introdução à Psiquiatria. Porto Alegre: Artmed.


  1. De Alvarenga PG, de Andrade AG, 2008, Fundamentos em Psiquiatria. São Paulo: Manole.
Conflict of interest
The authors declare that there are no conflicts of interest that could be perceived as prejudicing the impartiality of the commentary.
Back to top
INNOSC Theranostics and Pharmacological Sciences, Electronic ISSN: 2705-0823 Published by AccScience Publishing